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Abstract
We compared the effects of genistein and daidzein on the expression of chemokines, cell adhesion molecules (CAMs), and endothelial nitric
oxide synthase (eNOS) in tumor necrosis factor (TNF)-α-stimulated human umbilical vascular endothelial cells (HUVECs). TNF-α exposure significantly
increased expression of monocyte chemoattractant protein (MCP)-1, vascular adhesion molecule (VCAM)-1, and intercellular adhesion molecule-1. 
Genistein significantly decreased MCP-1 and VCAM-1 production in a dose-dependent manner, whereas CAM expression was not significantly lowered
by genistein treatment. However, daidzein slightly decreased MCP-1 production. The effects of genistein and daidzein on MCP-1 secretion coincided
with mRNA expression. Pre-treatment with either genistein or daidzein elevated eNOS expression and nitric oxide production disturbed by TNF-α
exposure. A low concentration of isoflavones significantly inhibited nuclear factor (NF)κB activation, whereas a high dose slightly ameliorated these
inhibitive effects. These results suggest that genistein had a stronger effect on MCP-1 and eNOS expression than that of daidzein. Additionally, 
NFκB transactivation might be partially related to the down-regulation of these mRNAs in TNF-α-stimulated HUVECs. 
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Introduction2)
Several lines of evidence suggest that soy isoflavones exert 
anti-atherogenic effects in mice, rabbits, monkeys, and humans 
[1-4]. Antihypertensive effects of isoflavones have also been 
proposed in spontaneously hypertensive rats and humans with 
mild to moderate essential hypertension [5-7]. The early stage 
of atherosclerosis is characterized by increased levels of infla-
mmatory cytokines, oxidative stress, and the expression of 
adhesion molecules on vascular endothelium. Various cell adhesion 
molecules (CAMs), such as vascular cell adhesion molecule 
(VCAM)-1, intercellular adhesion molecule (ICAM)-1, and 
monocyte chemoattractant protein (MCP)-1, have been identified 
in endothelial cells [8,9]. Expression of CAMs and MCP-1 in 
endothelial cells is stimulated by interleukin (IL)-1β, tumor 
necrosis factor (TNF)-α, and lipopolysaccharide (LPS), which 
serve as signals to facilitate nuclear factor (NF)κB transactivation 
[10-12]. CAM expression is closely related to NFκB up- 
regulation [8,13]. The endothelium also produces nitric oxide 
(NO), synthesized by endothelial nitric oxide synthase (eNOS), 
which is a vasoprotective and anti-atherosclerotic agent [5,6,14]. 
An eNOS isoform is constitutively expressed and can be activated 
and inhibited by phosphorylation through various protein kinases 
[5,15-17]. Therefore, any chemicals that suppress CAMs or 
enhance eNOS activity and expression in the vascular endothelium 
may be usable as therapeutic agents against the development of 
atherosclerosis. 
Soy isoflavones are comprised of genistein (4’,5,7-trihydroxy- 
isoflavone), daidzein (4’,7-dihydroxyisoflavone), glycitein (6-meth-
oxydaidzein), and their glycosides. The molecular mechanisms 
of how these isoflavones affect the development and progression 
of atherosclerosis has not been thoroughly studied. However, 
genistein, a protein kinase inhibitor, exhibits anti-oxidative and 
anti-inflammatory activities, such as scavenging free radicals to 
prevent reactive oxygen species (ROS)-mediated DNA damage 
[18-21] and suppression of NO production through down- 
regulation of inducible NOS (iNOS) expression and NFκB 
transactivation [16,17,22]. However, contradicting data have been 
reported on the effect of genistein on CAM activities and mRNA 
expression induced by TNF-α in endothelial cells [11,12,23]. 
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Primer Sequence (5’-3’) Amplicon (bp)
eNOS Forward: GTGTTTGGCCGAGTCCTCACC 342
Reverse: CTCCTGCAAGGAAAAGCTCTG
VCAM-1 Forward: CCCTTGACCGGCTCCAGATT 241
Reverse: CTGGGGGCAACATTGACATAAAGTG
ICAM-1 Forward: TATGGCAACGACTCCTTCT 238
Reverse: CATTCAGCGTCACCTTGG
MCP-1 Forward: CAGCCAGATGCAATCAATGC 198
Reverse: GTGGTCCATGGAATCCTGAA
GAPDH Forward: GAGTCAACGGATTTGGTCGT 482
Reverse: GTTGTCATGGATGACCTTGG
Table 1. RT-PCR primers used  Furthermore, little information is available about the effects of 
daidzein, another major component of soy isoflavones, on NFκB 
activity and eNOS expression, which regulate CAM expression 
and bioactive NO production in endothelial cells. These questions 
led us to compare the effects of genistein and daidzein on MCP-1, 
eNOS, and CAM expression in TNF-α-stimulated human 
umbilical vascular endothelial cells (HUVECs) and to investigate 
possible mechanisms of action of their anti-atherosclerotic effect. 
Materials and Methods
Materials
Genistein and daidzein were purchased from Sigma (St. Louis, 
MO, USA). EGM-2 Bullet Kit, HBSS, trypsin/EDTA solution, 
and trypsin neutralizing solution were obtained from Lonza 
(Basel, Switzerland). Human sVCAM-1 and MCP-1 enzyme 
linked immunosorbent assay (ELISA) kits were purchased from 
R&D Systems (Minneapolis, MN, USA). 
Cell culture and treatment 
HUVECs were purchased from Modern Tissue Technologies 
Inc. (Seoul, South Korea) and cultured in 75-cm
2 flasks with 
medium from the EGM-2 Bullet Kit, which contained 10% fetal 
bovine serum, hydrocortisone, human fibroblastic growth factor- 
B, vascular endothelial growth factor, R3-insulin-like growth 
factor-I, ascorbic acid, human epidermal growth factor, GA-1000, 
and heparin. Confluent cultures were washed with HEPES 
buffered saline solution. The collected cells were pelleted by 
centrifugation at room temperature for 10 min at 500 × g, the 
supernatant was discarded, and the cell pellet was gently 
resuspended in EGM-2 Bullet Kit medium. HUVECs were 
seeded at a density of 1 × 10
6 cells/100 mm dish and incubated 
for 2 days at 37℃  in a humidified 5% CO2 incubator. The 
medium was replaced every 2 days until confluence (3-5 days). 
Genistein and daidzein were dissolved in dimethyl sulfoxide and 
stored at -20℃. Cells were pretreated with or without genistein 
and daidzein (20, 50, or 100 μM) for 2 hr before stimulation 
with or without TNF-α (10 ng/mL) for 20 hr. Endothelial cell 
cultures were used at passages 3-6 in all experiments. 
Cell viability 
Cell viability was assessed by measuring the uptake of neutral 
red supravital dye by viable cells according to the procedure of 
Fautz  et al. [24]. After culturing the cells as described above, 
the medium was removed and replaced with 0.5 mL fresh 
medium containing 1.14 mM neutral red. After a 3-hr incubation, 
the medium was removed, and the cells were washed twice with 
phosphate buffered saline solution (pH 7.4). The incorporated 
neutral red was released from the cells by a 15-min incubation 
at room temperature in 1 mL of cell lysis buffer. To measure 
the dye taken up, the cell lysis products were centrifuged and 
absorbance of the supernatant was measured spectrophotometrically 
at 540 nm. 
sVCAM-1 and MCP-1 analysis 
The concentrations of sVCAM-1 and MCP-1 were measured 
in the culture supernatants utilizing a highly sensitive ELISA 
according to the manufacturer's instructions (R&D Systems Inc.). 
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
analysis 
Total RNA was isolated using Trizol-reagent (Invitrogen, 
Carlsbad, CA, USA) and first strand cDNA was synthesized using 
the Superscript First Strand cDNA Synthesis kit (Invitrogen), 
according to the manufacturer’s methods. The PCR primer 
sequences are shown in Table 1. The amplification profile 
consisted of an initial denaturation at 94℃ for 5 min followed 
by denaturation at 94℃, annealing from 58℃  to 63℃  and 
extension at 72℃ for 1 min. The total number of cycles for the 
best amplification profiles was 35, 22, 30, 22, and 20 for eNOS, 
VCAM-1, ICAM-1, MCP-1, and GAPDH, respectively. The 
intensity of the PCR products was densitometrically measured 
using the Gel Doc EQ System (Bio-Rad, Hercules, CA, USA). 
All signals were normalized to GAPDH house keeping gene 
mRNA levels and expressed as ratios.
NO production 
Nitrite that accumulated in the culture medium was used as 
an indicator of NO production according to the Griess reaction 
[25]. One hundred μL of each medium supernatant was mixed 
with 50 μL of 1% sulfanilamide (in 5% phosphoric acid) and 50 
μL of 0.1% naphthylenediamine dihydrochloride and incubated 
at room temperature for 10 min. The absorbance was measured 
at 550 nm against a NaNO2 serial dilution standard curve, and 
nitrite production was determined. Hye Yeon Cho et al. 383
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Fig. 1. Effects of genistein and daidzein on cell viability in tumor necrosis factor (TNF)-α-stimulated human umbilical vascular endothelial cells (HUVECs). Cells (1
×1 0
5 cells) in 96-well plates were preincubated with and without the indicated concentrations of genistein or daidzein for 2 hr and then incubated with TNF-α (10 ng/mL) 
for  20  hr.  Data  represent  the  means ± SD  of  triplicate  experiments.  Values  sharing  the  same  superscript  are  not  significantly  different  at  P < 0.05.
Electrophoretic mobility shift assay (EMSA)
Nuclear protein was extracted with a slight modification of 
the protocol from Dignam et al. [26]. Cells in 10 mm dishes 
were lysed with buffer, vortexed, kept on ice for 5 min, and 
centrifuged at 500 × g for 5 min at 4℃. Pelleted nuclei were 
resuspended in 50 μL extraction buffer. Following gentle mixing 
and an incubation on ice for 20 min, the samples were centrifuged 
at 500 × g for 5 min at 4℃. The supernatant fraction was 
transferred to new tubes and stored at -70℃. Protein concentra-
tion was determined by the Bradford assay. For the EMSA, NFκ
B-specific oligonucleotide was end-labeled with [γ-
32P]-ATP 
using T4 polynucleotide kinase (Promega, Madison, WI, USA) 
and purified using a Microspin G-25 column (GE Healthcare, 
Buckinghamshire, UK). EMSAs were performed according to the 
Promega instruction manual. Five μg of nuclear protein, binding 
buffer, 
32P-labeled NFκB, and loading buffer were incubated for 
30 min at room temperature. DNA-protein complexes were 
separated from unbound DNA probe by electrophoresis on 4% 
polyacrylamide gels with 0.5 × Tris-Borate EDTA buffer used 
as the running buffer. The gels were exposed to a phosphor 
screen (PerkinElmer, Waltham, MA, USA) for 2 hr at -20℃, 
and the bands were quantified with a phosphor imager 
(PerkinElmer). 
Statistical analysis
All data are expressed as means ± SDs. Statistical analyses 
were performed using the SPSS program (SPPS, Inc., Chicago, 
IL, USA. A one-way analysis of variance and Duncan’s multiple 
range test were used to examine the differences among treat-
ments.  P-values < 0.05 were considered significant. 
Results
Effects of genistein and daidzein on MCP-1 and CAMs
To examine the effects of genistein and daidzein on the 
expression of MCP-1 and CAMs, HUVECs were exposed to 
different concentrations (20-100 μM) of either genistein or 
daidzein and then stimulated with TNF-α. Cell viability was >
95% at the concentrations treated, as assessed by the neutral 
red assay (Fig. 1). Exposure of HUVECs to TNF-α induced 
significant MCP-1 and CAM expression, such as VCAM-1 and 
ICAM-1. Pre-incubation with genistein significantly (P <0 . 0 5 )  
decreased MCP-1 expression and production in a dose-dependent 
manner (Fig. 3A, 4A, and 4B). VCAM-1 production also 
decreased with genistein treatment (Fig. 2A), whereas VCAM-1 
and ICAM-1 mRNA expression was not significantly decreased 
by genistein treatment (Fig. 4). However, daidzein did not affect 
VCAM-1 and ICAM-1 mRNA expression or VCAM-1 produc-
tion (Fig. 2B, 5). Instead, MCP-1 production and expression were 
slightly lowered by daidzein treatment (Fig. 3B, 5), and its effect 
was smaller than that of genistein. These data suggest that 
genistein had a stronger effect on MCP-1 and CAM expression 
than that of daidzein.
Effects of genistein and daidzein on NO production 
Exposure of HUVECs to TNF-α downregulated eNOS expre-
ssion and caused a significant decrease in NO production. 
Pre-treatment of genistein and daidzein with TNF-α significantly 
elevated eNOS expression and NO production (P< 0.05, Fig. 6). 
Effects of genistein and daidzein on NFκB transactivation
TNF-α induced NFκB transactivation in HUVECs. Pre-incuba-
ting HUVECs with 20 μM genistein or daidzein inhibited NFκB 384 Comparison of genistein and daidzein on MCP-1 expression
(A) (B)
Fig. 2. Inhibitory effects of genistein and daidzein on vascular adhesion molecule (VCAM)-1 production in tumor necrosis factor (TNF)-α-stimulated human umbilical 
vascular endothelial cells (HUVECs). Cells (4 × 10
5  cells) in  24 -w ell p lates w ere p reincu b ated  w ith  an d  w itho u t th e indicated concentrations of genistein or daidzein for 
2 hr and then incubated with TNF-α (10 ng/mL) for 20 hr. Data represent the means ± SD of triplicate experiments. Values sharing the same superscript are not significantly 
different  at  P < 0.05.
(A) (B)
Fig. 3. Inhibitory effects of genistein and daidzein on monocyte chemoattractant protein (MCP)-1 production in tumor necrosis factor (TNF)-α-stimulated human umbilical 
vascular endothelial cells (HUVECs). Cells (4 × 10
5  cells) in  24 -w ell p lates w ere p reincu b ated  w ith  an d  w itho u t th e indicated concentrations of genistein or daidzein for 
2 hr and then incubated with TNF-α (10 ng/mL) for 20 hr. Data represent the means ± SD of triplicate experiments. Values sharing the same superscript are not significantly 
different  at  P < 0.05.
(A) (B)
Fig. 4. Effects of genistein on mRNA gene expression in tumor necrosis factor (TNF)-α-stimulated human umbilical vascular endothelial cells (HUVECs). Cells  (1
×1 0
6 cells) in  10 0  m m  d ish es w ere p rein cu b ated  w ith  and  w itho u t the indicated  concentrations  of  genistein for 2  hr  and  then incubated  with  TNFα  (10  ng/mL)  for  20 
hr. Untreated represents the negative control without TNF-α treatment. (A) Levels of mRNA were determined by RT-PCR analysis. GAPDH was used as an internal control. 
(B) All signals were normalized to GAPDH mRNA levels and expressed as ratios. Data represent means ± SD of triplicate experiments. Values sharing the same superscript 
are  not  significantly  different  at  P < 0.05.Hye Yeon Cho et al. 385
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Fig. 5. Effects of daidzein on mRNA gene expression in tumor necrosis factor (TNF)-α-stimulated human umbilical vascular endothelial cells (HUVECs). Cells  (1
×1 0
6  cells)  in  100  mm  dishes  were  preincubated  with  and  without  the  indicated  concentrations  of  daidzein  for  2  hr  and  then  incubated  with  TNFα  (10  ng/mL)  for  20 
hr. Untreated represents the negative control without TNF-α treatment. (A) Levels of mRNA expression were determined by RT-PCR analysis. GAPDH was used as an internal
control. (B) All signals were normalized to GAPDH mRNA levels and expressed as ratios. Data represent the means ± SD of triplicate experiments. Values sharing the same 
superscript  are  not  significantly  different  at  P < 0.05.
(A) (B)
Fig. 6. Effects of genistein and daidzein on nitric oxide (NO) production in tumor necrosis factor (TNF)-α-stimulated human umbilical vascular endothelial cells 
(HUVECs). Cells (4 × 10
5  cells) in 24-well plates were preincubated with and without the indicated concentrations of genistein or daidzein for 2 hr and then incubated with 
TNF-α  (10  ng/mL)  for  20  hr.  Data  represent  the  means ± SD  of  triplicate  experiments.  Values  sharing  the  same  superscript  are  not  significantly  different  at  P < 0.05.
(A) (B)
Fig. 7. Effects of genistein and daidzein on nuclear factor (NF)κB activity in tumor necrosis factor (TNF)-α-stimulated human umbilical vascular endothelial cells 
(HUVECs).  Cells (1 × 10
6 cells) in 100 mm dishes were preincubated with and without the indicated concentrations of genistein or daidzein for 2 hr and then incub ated 
with TNF-α (10 ng/mL) for 20 hr. (A) DNA binding activity of NFκB was assessed by electrophoretic mobility shift assay (EMSA)(B) Values are expressed as relative intensity 
of  radioactivity.  Data  represent  the  means ± SD  of  triplicate  experiments.  Values  sharing  the  same  superscript  are  not  significantly  different  at  P < 0.05.386 Comparison of genistein and daidzein on MCP-1 expression
activity. However, the inhibitory effect on NFκB transactivation 
was slightly ameliorated at > 50 μM (Fig. 7).
Discussion
Early development of atherosclerosis is closely related with 
oxidative stress and inflammatory processes, such as the expre-
ssion of chemokines and CAMs on endothelial cells. Several 
studies have reported that genistein and isoflavone supplementa-
tion in animal models improves endothelial dysfunction by 
regulating CAM and eNOS levels [2,5,6,8]. However, human 
trials do not consistently support the protective effects of higher 
isoflavone intake on cardiovascular disease risk [27], which 
might be due to the composition of the isoflavones used, study 
duration, or the supplementation amount. Therefore, this study 
was designed to compare the efficacy of genistein and daidzein, 
major soy isoflavones, on the regulation of chemokines, CAMs, 
and eNOS levels. 
Genistein had a stronger inhibitory effect than daidzein on 
MCP-1 and CAM expression and production. Pro-inflammatory 
cytokines, such as TNF-α and IL-1β, are well known inducers 
of vascular adhesion molecules, including VCAM-1 and MCP-1 
[10,11,28]. Tyrosine kinase inhibitors block transactivation of NF
κB, a transcription factor that regulates CAMs and is induced 
by TNF-α  and IL-1β  [11,12,23]. Our study revealed that 
genistein, a tyrosine kinase inhibitor, selectively suppressed TNF-
α-stimulated production of VCAM-1 and MCP-1 but not ICAM-1 
mRNA expression. Furthermore, our study showed that genistein 
is not an effective VCAM-1 inhibitor compared to that of MCP-1. 
The inhibition of MCP-1 expression was dose-dependent and 
correlated with soluble MCP-1 concentrations. May et al. [11] 
found that genistein inhibits VCAM-1 expression induced by 
TNF-α or IL-1 in HUVECs, whereas it does not affect ICAM-1 
expression. The selectivity of genistein for MCP-1 and VCAM-1 
regulation may be desirable, as ICAM-1 is involved in leukocyte 
adhesion, whereas MCP-1 and VCAM-1 are primarily involved 
in adhesion of monocytes and lymphocytes found in atherosc-
lerotic lesions [29]. However, CAM regulation may be affected 
by stimulus type. Weber et al. [28] reported that genistein does 
not affect CAM upregulation by phorbol myristic acid. Majewska 
et al. [13] also found that pre-treatment of HUVECs with 
genistein (10 μg/mL) for 30 min before IL-1 stimulation does 
not affect ICAM-1 and VCAM-1 expression. Chen et al. [30] 
found that isoflavoids have no obvious effect on neutrophilic 
CAM expression and concluded that isoflavoids protect the 
cardiovascular system through other mechanisms but not CAM 
regulation. Furthermore, genistein is ineffective for reducing 
LPS-stimulated E-selectin expression in HUVECs [12].
In contrast, daidzein showed very weak suppressive effects 
against MCP-1 expression and soluble protein excretion but no 
effect on ICAM-1 and VCAM-1 levels up to 100 μM. Gottstein 
et al. [23] also reported that daidzein decreases TNF-α-induced 
secretion of MCP-1 in HUVECs. However, we found that 
daidzein exerted weaker inhibitory effects than those of genistein 
for the expression of all CAMs. Our data agree with prior 
findings that genistein is a stronger suppressor of CAM 
expression than that of daidzein in TNF-α-stimulated HUVECs. 
Moreover, the present data contributes to our knowledge of the 
molecular mechanisms by which isoflavones may protect against 
coronary artery disease. 
Genistein improves vascular reactivity by regulating eNOS, 
though the molecular mechanism is not clear. Our results showed 
that NO production and eNOS expression were elevated by 
preincubating HUVECS with genistein before TNF-α stimulation. 
Several studies have confirmed the stimulatory effect of genistein 
on NO and eNOS levels. Genistein acutely stimulates eNOS 
synthesis in vascular endothelial cells within a 10 minute incuba-
tion period through the cAMP/protein kinase A cascade without 
affecting PI3K/Akt or the ERK/MAPK signaling pathways [15]. 
Furthermore, genistein supplementation in spontaneously hyper-
tensive rats shows a direct effect on transcription in vascular 
walls, leading to increased eNOS expression, thereby improving 
hypertension [5,7]. In contrast, soy isoflavone does not affect 
eNOS expression in Watanabe heritable hyperlipidemic rabbits 
[31]. These findings suggest that eNOS can be regulated by 
genomic and nongenomic actions.
Studies reporting the effect of daidzein on eNOS levels are 
scarce. In our study, the significance of genistein and daidzein 
on NO production and eNOS expression was compared. 
Genistein (20 μM) significantly elevated NO production and 
eNOS expression, whereas daidzein showed a significant difference 
only at 100 μM. Thus, daidzein was less effective at enhancing 
NO production and eNOS expression than genistein. The 
mechanism by which daidzein regulates eNOS seems to be 
somewhat different than that of genistein. Woodman et al. [32] 
proposed that daidzein enhances eNOS activity through an 
increase in calmodulin and a decrease in caveolin-1.
MCP-1 and CAM expression in endothelial cells is stimulated 
by IL-1β, TNF-α, and LPS, which serve as signals facilitating 
NFκB transactivation [10-12,33]. Our results indicated that both 
genistein and daidzein down-regulated CAM expression, and that 
this action was mediated, in part, through down-regulation of 
NFκB transactivation. Although we have demonstrated that TNF-
α  rapidly induced NFκB nuclear translocation in HUVECs, 
genistein and daidzein did not block NFκB translocation in a 
dose-dependent manner. In this study, the effects of genistein 
and daidzein on NFκB transactivation were biphasic; 20 μM of 
either isoflavone suppressed NFκB transactivation, whereas > 50 
μM slightly increased NFκB transactivation. A similar trend was 
found by Guo et al. [34], who reported that daidzein stimulates 
cancer cell growth at low concentrations (1 μM) but inhibits cell 
growth at higher concentrations. This implies that regulation of 
CAM expression by genistein and daidzein is not solely 
dependent on the NFκB signaling pathway. Several researchers 
have reported that regulation of CAM expression does not Hye Yeon Cho et al. 387
necessarily require the NFκB signaling pathway but depends on 
the stimulus and cell type. That is, genistein as a tyrosine kinase 
cannot block NFκB translocation at the concentration that inhibits 
iNOS and COX-2 mRNA expression in rat mesangial cells [35]. 
IL-4-induced upregulation of the VCAM-1 gene in HUVECs 
does not appear to be involved with NFκB at the transcriptional 
level [36].
From the above results, it can be concluded that genistein and 
daidzein significantly suppressed MCP-1 and VCAM-1 production 
and elevated eNOS expression in TNF-α-stimulated HUVECs, 
although the genisteineffect was stronger than that of daidzein. 
Amelioration of NFκB transactivation might be, in part, related 
to MCP-1 and CAM downregulation. The ability to regulate 
CAM and NFκB expression, which are activated in atherosclerotic 
lesions, may explain the molecular mechanisms of genistein and 
daidzein to retard development of the initial stage of athero-
sclerosis. Genistein and daidzein enhanced eNOS expression and 
NO production, which are promising results in the search for 
treatments to maintain healthy blood pressure and prevent 
atherosclerosis.
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